# FOXF1

## Overview
FOXF1, or forkhead box F1, is a gene that encodes a transcription factor belonging to the forkhead family, characterized by a distinct forkhead or winged-helix DNA-binding domain. This transcription factor plays a pivotal role in embryonic development and organogenesis, particularly influencing the development and function of the lungs and vasculature. The protein encoded by FOXF1 is involved in regulating mesenchymal cell migration and angiogenesis, acting as a downstream target of the Sonic hedgehog pathway and influencing various signaling pathways such as VEGF, PDGF, and Ang/Tie2. FOXF1's activity is modulated by post-translational modifications and alternative splicing, which contribute to its diverse roles in cellular processes. Mutations in the FOXF1 gene are associated with several congenital disorders, including alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), and have implications in certain cancers, highlighting its clinical significance (Sturtzel2018FOXF1; Malin2007Forkhead; Dharmadhikari2015Genomic; Ren2014FOXF1).

## Structure
FOXF1 (forkhead box F1) is a transcription factor characterized by a distinct forkhead or winged-helix DNA-binding domain. This domain typically consists of about 100 amino acids forming a helix-turn-helix motif, which is crucial for its role in binding to DNA and regulating gene expression. The forkhead domain is a defining feature of the forkhead family of transcription factors, to which FOXF1 belongs.

The protein's structure allows it to participate in various biological processes, including embryonic development and organogenesis. Post-translational modifications, such as phosphorylation, can regulate the activity of FOXF1, potentially altering its ability to bind DNA or interact with other proteins. These modifications are essential for the dynamic regulation of its function in different cellular contexts.

FOXF1 may also exist in multiple isoforms due to alternative splicing, which can lead to variations in its structure and function. These splice variants might have diverse roles in cellular processes, although specific details about the differences in structure between these isoforms are not provided in the available context. The presence of these isoforms suggests a level of complexity in the regulation and function of FOXF1 that is typical of transcription factors involved in critical developmental pathways.

## Function
The FOXF1 gene encodes a transcription factor that plays a crucial role in various biological processes, particularly in the development and function of the lungs and vasculature. In healthy human cells, FOXF1 is involved in the regulation of mesenchymal cell migration, which is essential for the morphogenesis and repair of organs such as the lung, liver, and gallbladder. This function is mediated through the direct transcriptional activation of integrin-beta3 (Itgβ3), a key component in cell migration (Malin2007Forkhead).

FOXF1 is also integral to the development of the pulmonary vasculature and mesoderm differentiation, acting as a downstream target of the Sonic hedgehog pathway. It regulates the expression of genes critical for angiogenesis and vascular development, including those involved in VEGF, PDGF, and Ang/Tie2 signaling pathways (Dharmadhikari2015Genomic). In endothelial cells, FOXF1 promotes angiogenesis by regulating the expression of VEGF receptors and other endothelial-specific genes, contributing to the formation and maintenance of vascular structures (Ren2014FOXF1).

In endothelial progenitor cells, FOXF1 enhances sprouting capacity, which is crucial for blood vessel formation. It upregulates the expression of Notch2 receptors and other proteins associated with high sprouting activity, indicating its significant role in vascular development and endothelial progenitor functions (Sturtzel2018FOXF1).

## Clinical Significance
Mutations and alterations in the FOXF1 gene are primarily associated with alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), a rare and often fatal congenital lung disorder. ACDMPV is characterized by the misalignment of pulmonary veins, medial thickening of pulmonary arteries, and decreased capillaries, leading to severe respiratory distress and pulmonary hypertension in newborns (Wang2024Identification; Dharmadhikari2015Genomic). Mutations in FOXF1, including heterozygous point mutations and deletions, are the main causes of this condition, often occurring de novo on the maternal chromosome (Sen2012A; Alsina2017Maternal).

FOXF1 mutations are also linked to other congenital anomalies, such as gastrointestinal and cardiovascular defects, and are implicated in conditions like pulmonary hypertension and bowel malrotation (Reiter2016Variable; Yu2010Haploinsufficiencies). In addition to developmental disorders, altered FOXF1 expression is associated with certain cancers. Epigenetic inactivation of FOXF1 has been reported in breast and colorectal cancers, while its overexpression is linked to medulloblastoma and rhabdomyosarcoma (Dharmadhikari2015Genomic). Understanding the genomic and epigenetic complexity of FOXF1 is crucial for diagnosing and treating these conditions (Dharmadhikari2015Genomic).

## Interactions
FOXF1, a transcription factor, engages in several physical interactions with proteins and nucleic acids to regulate gene expression. It directly binds to the promoter regions of various genes, including Acvrl1, Rras, Cdh2, and Cdh11, influencing their transcriptional activity. This binding is crucial for processes such as angiogenesis and fibrosis regulation (Bian2023Lung; Black2018FOXF1; Wang2022Endothelial).

FOXF1 interacts with the ETS transcription factor FLI1 to synergistically activate the Acvrl1 promoter, a key component of the BMP9 signaling pathway. This interaction is specific to FLI1, as FOXF1 does not show similar synergy with other ETS transcription factors like ERG and ETS1 (Wang2022Endothelial). The FOXF1-FLI1 interaction also extends to the regulation of FOXF1's own promoter, suggesting a feedback mechanism (Wang2022Endothelial).

In the context of pulmonary fibrosis, FOXF1 binds to the Rras promoter, enhancing its transcription and subsequently influencing the expression of inflammatory mediators such as CCL2 and TNFα (Bian2023Lung). FOXF1 also regulates the transcription of cadherin genes, activating Cdh2 and repressing Cdh11, which are involved in myofibroblast differentiation and function (Black2018FOXF1).


## References


[1. (Sturtzel2018FOXF1) Caterina Sturtzel, Karoline Lipnik, Renate Hofer-Warbinek, Julia Testori, Bettina Ebner, Jaqueline Seigner, Ping Qiu, Martin Bilban, Anita Jandrositz, Karl-Heinz Preisegger, Gerold Untergasser, Eberhard Gunsilius, Rainer de Martin, Jens Kroll, and Erhard Hofer. Foxf1 mediates endothelial progenitor functions and regulates vascular sprouting. Frontiers in Bioengineering and Biotechnology, June 2018. URL: http://dx.doi.org/10.3389/fbioe.2018.00076, doi:10.3389/fbioe.2018.00076. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fbioe.2018.00076)

[2. (Bian2023Lung) Fenghua Bian, Ying-Wei Lan, Shuyang Zhao, Zicheng Deng, Samriddhi Shukla, Anusha Acharya, Johnny Donovan, Tien Le, David Milewski, Matthew Bacchetta, Ahmed Emad Hozain, Yuliya Tipograf, Ya-Wen Chen, Yan Xu, Donglu Shi, Vladimir V. Kalinichenko, and Tanya V. Kalin. Lung endothelial cells regulate pulmonary fibrosis through foxf1/r-ras signaling. Nature Communications, May 2023. URL: http://dx.doi.org/10.1038/s41467-023-38177-2, doi:10.1038/s41467-023-38177-2. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-38177-2)

[3. (Reiter2016Variable) Joel Reiter, Przemyslaw Szafranski, Oded Breuer, Zeev Perles, Tamir Dagan, Paweł Stankiewicz, and Eitan Kerem. Variable phenotypic presentation of a novelfoxf1missense mutation in a single family: variable phenotype of a novel foxf1 mutation. Pediatric Pulmonology, 51(9):921–927, May 2016. URL: http://dx.doi.org/10.1002/ppul.23425, doi:10.1002/ppul.23425. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/ppul.23425)

[4. (Wang2024Identification) Guolun Wang, Bingqiang Wen, Minzhe Guo, Enhong Li, Yufang Zhang, Jeffrey A. Whitsett, Tanya V. Kalin, and Vladimir V. Kalinichenko. Identification of endothelial and mesenchymal foxf1 enhancers involved in alveolar capillary dysplasia. Nature Communications, June 2024. URL: http://dx.doi.org/10.1038/s41467-024-49477-6, doi:10.1038/s41467-024-49477-6. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-49477-6)

[5. (Black2018FOXF1) Markaisa Black, David Milewski, Tien Le, Xiaomeng Ren, Yan Xu, Vladimir V. Kalinichenko, and Tanya V. Kalin. Foxf1 inhibits pulmonary fibrosis by preventing cdh2-cdh11 cadherin switch in myofibroblasts. Cell Reports, 23(2):442–458, April 2018. URL: http://dx.doi.org/10.1016/j.celrep.2018.03.067, doi:10.1016/j.celrep.2018.03.067. This article has 68 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2018.03.067)

[6. (Malin2007Forkhead) Dmitriy Malin, Il-Man Kim, Evan Boetticher, Tanya V. Kalin, Sneha Ramakrishna, Lucille Meliton, Vladimir Ustiyan, Xiangdong Zhu, and Vladimir V. Kalinichenko. Forkhead box f1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. Molecular and Cellular Biology, 27(7):2486–2498, April 2007. URL: http://dx.doi.org/10.1128/mcb.01736-06, doi:10.1128/mcb.01736-06. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01736-06)

[7. (Dharmadhikari2015Genomic) Avinash V. Dharmadhikari, Przemyslaw Szafranski, Vladimir V. Kalinichenko, and Pawel Stankiewicz. Genomic and epigenetic complexity of the foxf1 locus in 16q24.1: implications for development and disease. Current Genomics, 16(2):107–116, March 2015. URL: http://dx.doi.org/10.2174/1389202916666150122223252, doi:10.2174/1389202916666150122223252. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/1389202916666150122223252)

[8. (Alsina2017Maternal) Miguel Alsina Casanova, Ana Monteagudo-Sánchez, Luciana Rodiguez Guerineau, Franck Court, Isabel Gazquez Serrano, Loreto Martorell, Carlota Rovira Zurriaga, Gudrun E. Moore, Miho Ishida, Montserrat Castañon, Elisenda Moliner Calderon, David Monk, and Julio Moreno Hernando. Maternal mutations offoxf1cause alveolar capillary dysplasia despite not being imprinted: casanova et al. Human Mutation, 38(6):615–620, March 2017. URL: http://dx.doi.org/10.1002/humu.23213, doi:10.1002/humu.23213. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23213)

[9. (Yu2010Haploinsufficiencies) Shihui Yu, Lei Shao, Howard Kilbride, and David L. Zwick. Haploinsufficiencies of foxf1 and foxc2 genes associated with lethal alveolar capillary dysplasia and congenital heart disease. American Journal of Medical Genetics Part A, 152A(5):1257–1262, April 2010. URL: http://dx.doi.org/10.1002/ajmg.a.33378, doi:10.1002/ajmg.a.33378. This article has 60 citations.](https://doi.org/10.1002/ajmg.a.33378)

[10. (Sen2012A) Partha Sen, Romana Gerychova, Petr Janku, Marta Jezova, Iveta Valaskova, Colby Navarro, Iris Silva, Claire Langston, Stephen Welty, John Belmont, and Pawel Stankiewicz. A familial case of alveolar capillary dysplasia with misalignment of pulmonary veins supports paternal imprinting of foxf1 in human. European Journal of Human Genetics, 21(4):474–477, September 2012. URL: http://dx.doi.org/10.1038/ejhg.2012.171, doi:10.1038/ejhg.2012.171. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2012.171)

[11. (Ren2014FOXF1) Xiaomeng Ren, Vladimir Ustiyan, Arun Pradhan, Yuqi Cai, Jamie A. Havrilak, Craig S. Bolte, John M. Shannon, Tanya V. Kalin, and Vladimir V. Kalinichenko. Foxf1 transcription factor is required for formation of embryonic vasculature by regulating vegf signaling in endothelial cells. Circulation Research, 115(8):709–720, September 2014. URL: http://dx.doi.org/10.1161/CIRCRESAHA.115.304382, doi:10.1161/circresaha.115.304382. This article has 128 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/CIRCRESAHA.115.304382)

[12. (Wang2022Endothelial) Guolun Wang, Bingqiang Wen, Zicheng Deng, Yufang Zhang, Olena A. Kolesnichenko, Vladimir Ustiyan, Arun Pradhan, Tanya V. Kalin, and Vladimir V. Kalinichenko. Endothelial progenitor cells stimulate neonatal lung angiogenesis through foxf1-mediated activation of bmp9/acvrl1 signaling. Nature Communications, April 2022. URL: http://dx.doi.org/10.1038/s41467-022-29746-y, doi:10.1038/s41467-022-29746-y. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29746-y)